Explore UAB
Hugh Kaul Precision Medicine Institute • November 18, 2026

Andy Crouse and Aleksandra Foksinska represent the UAB Center for Precision Animal Modeling (CPAM) at the 2026 American Society of Human Genetics Annual Meeting in Montreal, Canada. They stand beside an exhibit featuring information about CPAM's patient-inspired approach to developing precision disease models.The UAB Center for Precision Animal Modeling (CPAM) connected with researchers and clinicians at the 2026 American Society of Human Genetics (ASHG) Annual Meeting in Montreal, Canada, to highlight the center's resources and capabilities in advancing genetic research.

CPAM serves as a national resource, funded by the NIH, for researchers, clinicians, and patient groups, developing precision disease models that help scientists understand how genetic changes contribute to disease. Using experimental, cellular, and computational systems, the center helps researchers investigate disease mechanisms and explore potential treatment opportunities.

Andrew Crouse, director of research and operations at the UAB Hugh Kaul Precision Medicine Institute, and Aleksandra Foksinska, program manager at the UAB Hugh Kaul Precision Medicine Institute, represented CPAM at the conference. Their attendance focused on increasing awareness of the center and connecting with potential external collaborators interested in developing models to study genetic variants and diseases.

ASHG brings together researchers, clinicians, students, and patient advocates from across the human genetics community. Throughout the conference, Crouse and Foksinska spoke with attendees about CPAM's model development capabilities and opportunities to collaborate with the center.

CPAM works with a variety of model systems, including mice, rats, frogs, zebrafish, and cells. By studying how specific genetic variants affect biological systems, researchers can better understand disease processes and investigate potential therapeutic approaches.

The team also brought a creative touch to its outreach, offering small packets of gummy candies representing the different model systems used by the center. The giveaways served as conversation starters and helped introduce attendees to CPAM's work.

CPAM's participation in ASHG reflects UAB's continued efforts to build collaborations within the human genetics community and connect researchers with the resources and expertise needed to better understand genetic conditions and advance precision medicine research.

CPAM is led by Bradley Yoder, Ph.D., professor and chair in the Department of Cell, Developmental and Integrative Biology, and co-directors Matt Might, Ph.D., professor in the Department of Medicine and director of the Hugh Kaul Precision Medicine Institute, and Elizabeth Worthey, Ph.D., associate professor in the Department of Genetics.

For more information about CPAM, visit the CPAM website or email This email address is being protected from spambots. You need JavaScript enabled to view it..


Subscribe to Heersink
School of Medicine News

Subscribe to Heersink School of Medicine News